Latest News for: q32

Edit

Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants

Morgan Citizen 15 Jul 2026
WALTHAM, Mass., July 14, 2026 /PRNewswire/ -- Q32 Bio ...
Edit

Notice of Effectiveness (Form EFFECT) (Q32 Bio Inc)

Public Technologies 14 Jul 2026
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549 ... Q32 Bio Inc ... Q32 Bio Inc.
Edit

Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial ...

Rocky Mount Telegram 13 Jul 2026
-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline of 35.3% in the prespecified mITT analysis -- ....
Edit

Material Event (Form 8-K) (Q32 Bio Inc)

Public Technologies 13 Jul 2026
). The text version of this document is not available ... Q32 Bio Inc.
Edit

Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata (Form 8-K) (Q32 Bio Inc)

Public Technologies 13 Jul 2026
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata ... - Q32 Bio to host conference call and webcast today, July 13, 2026, at 8.00 a.m ... About Q32 Bio ... Q32 Bio Inc.
Edit

Why Q32 Bio investors should take profits in the stock after 81% rally

Invezz 13 Jul 2026
Q32 Bio (QTTB) shares doubled on Monday as the clinical-stage biotech firm announced positive 36-week topline data from Part B of its Phase 2a SIGNAL-AA trial ... Including today’s rally, Q32 Bio stock is ...
Edit

Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

PR Newswire 13 Jul 2026
WALTHAM, Mass., July 13, 2026 /PRNewswire/ -- Q32 Bio Inc ... All of the shares of common stock and pre-funded warrants to be sold in the proposed offering will be sold by Q32 Bio ... About Q32 Bio ... SOURCE Q32 Bio.
Edit

Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata

PR Newswire 13 Jul 2026
-- Q32 Bio to host conference call and webcast today, July 13, 2026, at 8.00 a.m ... WALTHAM, Mass., July 13, 2026 /PRNewswire/ -- Q32 Bio Inc ... About Q32 Bio ... Availability of Other Information About Q32 Bio ... SOURCE Q32 Bio.
Edit

Supplemental Prospectus (Form 424B5) (Q32 Bio Inc)

Public Technologies 13 Jul 2026
and referred to herein as Legacy Q32), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology (the "Merger") ... and referred to herein as Legacy Q32), with ...
Edit

Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of ...

Morgan Citizen 11 Jul 2026
-- Conference call to be held Monday, July 13th at 8.00 a.m. E.T. -- ... .
Edit

Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026

PR Newswire 10 Jul 2026
WALTHAM, Mass., July 10, 2026 /PRNewswire/ -- Q32 Bio Inc ... Following the announcement, Q32 Bio will host a conference call and webcast at 8.00 a.m ... About Q32 Bio ... Availability of Other Information About Q32 Bio ... SOURCE Q32 Bio.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Q32 Bio Inc)

Public Technologies 02 Jul 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number. 3235-0287 ... 2 ... Q32 Bio Inc ... Q32 BIO INC., 830 WINTER STREET 3 ... Q32 BIO INC ... Q32 Bio Inc.
Edit

Registration Statement - Specified Transactions (Form S-3) (Q32 Bio Inc)

Public Technologies 25 Jun 2026
Q32 BIO INC ... Q32 Bio Inc ... (previously named Q32 Bio Inc. and referred to herein as Legacy Q32), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology ... The consolidated financial statements of Q32 Bio Inc ... Q32 Bio Inc.
Edit

Proxy Results (Form 8-K) (Q32 Bio Inc)

Public Technologies 16 Jun 2026
) Item 5.07. Submission of Matters to a Vote of Security Holders. During the 2026 Annual Meeting of Stockholders (the "Annual Meeting") of Q32 Bio Inc ... Proposal No. 1 - Election of Class II Directors. ... Arthur Tzianabos, Ph.D ... Q32 Bio Inc ... (noodl.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Q32 Bio Inc)

Public Technologies 08 Jun 2026
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104. Estimated average burden hours per response... 0.5. (Print or Type Responses) 1. Name and Address of Reporting Person * ... 2 ... Q32 Bio Inc. [QTTB] ... 5 ... 5) ... Q32 Bio Inc.

Article Search

tools
×
×
×
×